The response deadline has passed. Review the details for future reference or to track similar opportunities.
The Department of Defense is seeking Cryopreserved Platelets (CPP) for US FDA licensure, specifically a biologic product that enhances the readiness and quality of life for active-duty personnel. The product aims to provide a longer shelf life compared to currently licensed liquid stored platelets.
The Defense Health Agency is developing a biologic product, Dimethyl Sulfoxide (DMSO) Cryopreserved Platelets (CPP), which is intended to improve the storage and usability of platelet-derived products for military personnel.
Sought after DEPT OF DEFENSE DEFENSE HEALTH AGENCY (DHA) pment in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) Defense Health Agency seeks to develop and manage medical materiel to protect and sustain the Warfighter on point for the Nation. We develop, directly through collaboration with commercial partners, medical products that enhance readiness and improve the quality of life of active-duty personnel in the operational environment. OPMED’s WPAC PMO has been developing a biologic product: Dimethyl Sulfoxide (DMSO) Cryopreserved Platelets (CPP), a frozen, biologic-platelet product. DMSO CPP are formulated to provide a platelet-derived product with a longer shelf life (2 years and potentially longer) than liquid stored platelets (LSP), which are currently licensed for storage up to 5-7 days at room temperature (20ºC to 24ºC) under gentle agitation. Peter Mitchell Alternative
Point of Contact Kelly Green Contracting (No Street Address
2) FORT DETRICK, MD 21702 USA to this opportunity.
Get matched to contracts like this daily
Free AI-powered contract matching for your business.